1325.3000 -0.80 (-0.06%)
NSE Jun 20, 2025 15:31 PM
Volume: 1.8M
 

1325.30
-0.06%
ICICI Securities Limited
US remains a key driver, contributing ~37% to revenues as of FY21. DRL has a strong pending pipeline comprising 92 ANDAs (47 Para IV filings, 23 FTFs) and three NDAs under 505 (b) (2) route. We expect US sales to grow...
Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
More from Dr. Reddy's Laboratories Ltd.
Recommended